ALYSE RUSSO: Open Payments
NPI 1346516408 · TEANECK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,814 in 112 payments from 18 companies in 2025. Trend: 2023 $3,522 · 2024 $1,370 · 2025 $1,814
Food & beverage: $1,715Education: $99
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $254 |
| Regeneron Healthcare Solutions, Inc. | 12 | $194 |
| MAYNE PHARMA COMMERCIAL LLC | 17 | $186 |
| Janssen Biotech, Inc. | 5 | $178 |
| ABBVIE INC. | 14 | $176 |
| PFIZER INC. | 8 | $161 |
| Novartis Pharmaceuticals Corporation | 8 | $157 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $74 |
| Amgen Inc. | 4 | $71 |
| Lilly USA, LLC | 3 | $53 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, CIBINQO, COSENTYX, ILUMYA, Winlevi, Cabtreo.
Industry payments across NJ — which companies pay providers there.
